Abstract
Background: Optic Pathway Gliomas (OPG) are the most common brain tumor in Neurofibromatosis 1 patients (NF1). They are found along the optic pathway and may involve the optic nerves, chiasm, retro-chiasmatic structures, and the optic radiations. NF1 associate OPG (NF1-OPG) have variable presentation, disease course and response to treatment. The optimal management is patient-specific and should be tailored by a multidisciplinary team. Age, sex, histology, and molecular markers may be important factors in the individualized decision-making process. Chemotherapy is the first-line treatment in cases of progressive tumors, and visual preservation is the main goal of treatment. Purpose: In this paper we will review the disease, practical management, and recent advances of NF1-OPG.
| Original language | English |
|---|---|
| Pages (from-to) | 2351-2361 |
| Number of pages | 11 |
| Journal | Child's Nervous System |
| Volume | 36 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Oct 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chemotherapy
- Low-grade glioma
- NF1
- Neurofibromatosis 1
- Neurosurgery
- OPG
- Optic pathway glioma
- Radiotherapy
Fingerprint
Dive into the research topics of 'Neurofibromatosis 1–associated optic pathway gliomas'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver